Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jul 26;4(7):234-9.
doi: 10.4330/wjc.v4.i7.234.

Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries

Affiliations

Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries

Joana Cortez et al. World J Cardiol. .

Abstract

Due to recent population emigration movements, an epidemic of Chagas disease is currently menacing most developed countries. The authors report the case of a 53-year-old Brazilian woman living in Europe for the last 10 years who developed heart failure symptoms, having a previous symptomatic sinus node disease with a pacemaker implant at age of 40 years. The diagnosis was based on serology and myocardial biopsy and the patient was treated with nifurtimox. The authors emphasize the need of a high level of suspicion in patients with suggestive epidemiology and the need of populational screening of specific high risk groups. New treatment options are also discussed.

Keywords: Benznidazole; Chagas cardiomyopathy; Chagas disease; Dysrhythmia; Emigration; Nifurtimox; Non-endemic countries.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Transthoracic echocardiogram: apical 4-chamber view (A), parasternal long-axis (B); and (C) left ventricle angiogram showing a dilated and aneurysmatic left ventricle (36.37 mm/m2 end diastolic and 31.44 mm/m2 end systolic diameter) with generalized hypokinesia.
Figure 2
Figure 2
T. cruzi pseudocyst (arrow). A: Heart muscle, Giemsa staining, 100×; B: Heart muscle, hematoxylin-eosin staining, 100×.

Similar articles

Cited by

References

    1. Basile L, Jansa JM, Carlier Y, Salamanca DD, Angheben A, Bartoloni A, Seixas J, Van Gool T, Canavate C, Flores-Chavez M, et al. Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill. 2011;16:pii 19968. - PubMed
    1. Available from: www.who.int/neglected_diseases/2010report/en/
    1. Pinazo MJ, Espinosa G, Gállego M, López-Chejade PL, Urbina JA, Gascón J. Successful treatment with posaconazole of a patient with chronic Chagas disease and systemic lupus erythematosus. Am J Trop Med Hyg. 2010;82:583–587. - PMC - PubMed
    1. Rassi A, Rassi A, Marin-Neto JA. Chagas disease. Lancet. 2010;375:1388–1402. - PubMed
    1. Telleria J, Tibayrenc M. American Trypanosomiasis: Chagas Disease One Hundred Years of Research (Elsevier Insights). 1st ed. Amsterdam : Elsevier. 2010:531–532.